Hamilton D V, Evans D B, Maidment G, Pryor J S
J R Soc Med. 1981 May;74(5):357-62.
The converting-enzyme inhibitor, captopril, was given to ten patients with refractory severe hypertension of renal origin: 6 patients had chronic renal failure, 3 patients had hypertension following renal transplantation, and one patient had hypertension and congestive cardiac failure. Control of blood pressure was achieved with doses from 78 to 400 mg/day. Severe hyperkalaemia occurred in one patients, ageusia (dose dependent) in another, and one patients withdrew from treatment because of nausea.
给10例顽固性肾源性重度高血压患者服用转换酶抑制剂卡托普利:6例患有慢性肾衰竭,3例在肾移植后出现高血压,1例患有高血压和充血性心力衰竭。通过每日78至400毫克的剂量实现了血压控制。1例患者出现严重高钾血症,另1例出现味觉丧失(剂量依赖性),1例患者因恶心退出治疗。